prothymosin alpha is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-17. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 3,108 Da | Consistent with a 28-residue acetylated peptide |
| Residue count | 28 | Corresponds to the amino terminal region of prothymosin alpha |
| Appearance of dry powder | White to off-white solid | Slight variation between lots is normal |
| Solubility class | Freely soluble in water | Low solubility in most organic solvents |
| Common synonyms | Thymosin alpha 1, T alpha 1 | The numeral reflects an early fraction numbering scheme |
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Deman acknowledges that Wolverine is a gruff loner who often takes leave from the X-Men to deal with personal issues or problems, irreverent and rebellious towards authority figures, and displays a wry, sarcastic sense of humor. Despite this, Deman also notes that Wolverine is a reliable ally and competent leader, as well as capable of warmth, compassion, and empathy. Clinical psychologist and Navy veteran Larry Yarbrough recognizes that while "Logan has an extremely reactive temper" he is "also a kind person", pointing out that the "violent/kind demeanor" he displays is typical of combat veterans. According to him, Wolverine's "violent mood swings are a symptom of trauma, not a reflection of his character". He also observes Wolverine's habitual smoking and drinking, which are coping mechanisms for his traumatic experiences. Psychologist Suzana E. Flores writes that Wolverine demonstrates clinical psychological symptoms of post-traumatic stress disorder, bipolar disorder, antisocial personality disorder, dissociative disorder, and even sociopathy, but does so in a way that can be understood and empathized. She interprets his origin story as a depiction of complex childhood trauma, and its effects of dissociative amnesia and hypervigilance. She argues that his first formative trauma was his poor relationship with his mother, who was unable to properly attach to him because she lost her first son. In adulthood, he also suffered the trauma of torture by the Weapon X program.
==== Cell selection ==== G418 is an aminoglycoside potent enough to kill mammalian cells. It is used in cell biology as a selective agent, killing off cells that have not taken up a resistance gene. When a genetic construct is inserted into a cell using a vector, biologists often use such a resistance gene as a selectable marker, allowing them to use a poison such as G418 to only keep the cells that have taken up the vector.
== Creation of pan-Slavic languages == Similarities of Slavic languages inspired many to create zonal auxiliary Pan-Slavic languages for all Slavic people to communicate with one another. Several such languages were constructed in the past, but many more were created in the Internet Age. The most prominent modern example is Interslavic.
From propionyl-CoA: Methylmalonyl-CoA results from the metabolism of fatty acid with an odd number of carbons, of amino acids valine, isoleucine, methionine, threonine or of cholesterol side-chains, forming Propionyl-CoA. The latter is also formed from propionic acid, which bacteria produce in the intestine. Propionyl-CoA and bicarbonate are converted to Methylmalonyl-CoA by the enzyme propionyl-CoA Carboxylase. It then is converted into succinyl-CoA by methylmalonyl-CoA mutase (MUT). This reaction is a reversible isomerization. In this way, the compound enters the citric acid cycle. The following diagram demonstrates the aforementioned reaction: Propionyl CoA + Bicarbonate → Methylmalonyl CoA → Succinyl CoA
Sources: en.wikipedia.org
Lactoferrin (LF), also known as lactotransferrin (LTF), is a multifunctional protein found in milk and mucus which is encoded by the LTF gene in humans. Lactoferrin functions as an antimicrobial protein, and also impacts the body's immune response in a complex way, with both pro- and anti-inflammatory effects. This protein is part of the transferrin family. Lactoferrin is a globular glycoprotein with a molecular mass of about 80 kDa that is widely represented in various secretory fluids, such as milk, saliva, tears, and nasal secretions. Lactoferrin is also present in secondary granules of PMNs and is secreted by some acinar cells. Lactoferrin can be purified from milk or produced recombinantly. Human colostrum ("first milk") has the highest concentration, followed by human milk, then cow milk (150 mg/L). Lactoferrin is one of the components of the immune system of the body; it has antimicrobial activity (bacteriocide, fungicide) and is part of the innate defense, mainly at mucosas. It is constantly produced and released into saliva, tears, as well as seminal and vaginal fluid. Lactoferrin provides antibacterial activity to human infants. Lactoferrin interacts with DNA and RNA, polysaccharides and heparin, and shows some of its biological functions in complexes with these ligands. Lactoferrin supplements reduce the risk of respiratory tract infections, based on a recent meta-analysis of randomized controlled trials.
Emily Maitlis, TV newscaster and reporter Winston Marshall (born 20 December 1987); journalist and podcaster; former Mumford & Sons musician; has written for Jewish Chronicle (on BDS), Daily Mail, Newsweek, Die Welt, Dissident Muse Journal, RealClear Politics, The Spectator, David Horowitz' Frontpage Magazine, Hot Press, Common Sense with Bari Weiss; has interviewed Eylon Levy, Natan Sharansky, Douglas Murray, mostly focusing on the Israel-Hamas conflict. Monty Meth (3 March 1926 – 14 March 2021) was a British journalist who was editor of the Daily Mail; was member of the Young Communist League;appointed Member of the Order of the British Empire (MBE) in the 2007 Queen's Birthday Honours for services to the communities of Enfield and Bethnal Green.; author of Here to Stay: A Study of Good Practices in the Employment of Coloured Workers 1972; Brothers to all Men? A Report on Trade Union Actions and Attitudes on Race Relations.
At temperatures greater than 44 °C (111 °F), proteins begin losing their three-dimensional shape and start breaking down. This results in cell and tissue damage. Many of the direct health effects of a burn are caused by failure of the skin to perform its normal functions, which include: protection from bacteria, skin sensation, body temperature regulation, and prevention of evaporation of the body's water. Disruption of these functions can lead to infection, loss of skin sensation, hypothermia, and hypovolemic shock via dehydration (i.e. water in the body evaporated away). Disruption of cell membranes causes cells to lose potassium to the spaces outside the cell and to take up water and sodium. In large burns (over 30% of the total body surface area), there is a significant inflammatory response. This results in increased leakage of fluid from the capillaries, and subsequent tissue edema. This causes overall blood volume loss, with the remaining blood suffering significant plasma loss, making the blood more concentrated. Poor blood flow to organs like the kidneys and gastrointestinal tract may result in kidney failure and stomach ulcers. Increased levels of catecholamines and cortisol can cause a hypermetabolic state that can last for years. This is associated with increased cardiac output, metabolism, a fast heart rate, and poor immune function.
In 2021, Pansino hosted the HBO Max series Baketopia where contestants competed in a bake-off to win up to $10,000; her hosting work on the show received praise and she also executive produced several episodes. In November 2024, Pansino started her own podcast series called the "Rodiculous Podcast", where she has interviews and conversations with celebrities and fellow YouTubers, with a lot of them being her friends.
Casgevy, a world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent beta thalassemia, is approved by the Medicines and Healthcare products Regulatory Agency, becoming the first drug using CRISPR to be licensed. 17 November Education Secretary Gillian Keegan says she is "deeply concerned" about children missing school to attend pro-Palestinian protests, after a number of school age children were seen at protests around the UK. After being found in breach of the Premier League's financial rules, Everton Football Club have 10 points deducted, leaving them 19th in the league's table. It is the biggest punishment in the Premier League's history. A study published by the Health Foundation finds that 12% of the UK's workforce has a work limiting health condition, a figure roughly equating to around 3.7m, and up from 8.5% a decade ago. These conditions are particular prevalent in the young. 19 November – Shadow Chancellor Rachel Reeves describes protests targeting MPs over the Gaza conflict as "crossing the line" after a demonstration was held near the offices of Labour leader Sir Keir Starmer the previous day. 20 November – The latest stage of the COVID-19 Inquiry hears from Sir Patrick Vallance, Chief Scientific Adviser during the pandemic.
Sources: en.wikipedia.org
1995: British geomorphologist Marjorie Sweeting published the first comprehensive Western account of China's karst, entitled Karst in China: its Geomorphology and Environment. 1995: Israeli-Canadian mathematical biologist Leah Keshet became the first female president of the international Society for Mathematical Biology. 1995: British geochemist Jane Plant became the first female deputy director of the British Geological Survey. 1995: Inspectors from the United Nations Special Commission discovered that Iraqi microbiologist Rihab Taha, nicknamed "Dr. Germ", had been overseeing a secret 10-year biological warfare development program in Iraq. 1996: American planetary scientist Margaret G. Kivelson led a team that discovered the first subsurface, saltwater ocean on an alien world, on the Jovian moon Europa. 1997: Lithuanian-Canadian primatologist Birutė Galdikas received the Tyler Prize for Environmental Achievement for her research and rehabilitation work with orangutans. Her work with orangutans, eventually spanning over 30 years, was later recognized in 2014 as one of the longest continuous scientific studies of wild animals in history. 1997: Chilean astronomer María Teresa Ruiz discovered Kelu 1, one of the first observed brown dwarfs. In recognition of her discovery, she became the first woman to receive the Chilean National Prize for Exact Sciences. 1998: Nurse Fannie Gaston-Johansson became the first African-American woman tenured full professor at Johns Hopkins University. Late 1990s: Ethiopian-American chemist Sossina M. Haile developed the first solid acid fuel cell.
=== Ho–Hu === Gladys Lounsbury Hobby (1910–1993), American microbiologist known for development and early understanding of antibiotics Dorothy Hodgkin (1910–1994), British chemist, 1964 Nobel Prize in chemistry for development of protein crystallography Jacobus Henricus van 't Hoff (1852–1911), Dutch physical chemist known for developing the princioles of chemical thermodynamics, 1901 Nobel Prize in Chemistry Albert Hofmann (1906–2008), Swiss chemist, synthesized Lysergic acid diethylamide (LSD) August Wilhelm Hofmann (1818–1892), German chemist, first to isolate sorbic acid Darleane C. Hoffman (1926–2025), American nuclear chemist who studied the properties of transuranium elements Friedrich Hoffmann (1660–1742), German physician and chemist who found that lime, magnesia, etc. existed in almost all mineral springs in Germany Roald Hoffmann (born 1937), Polish-born American chemist, 1981 Nobel Prize in Chemistry for theories of the course of chemical reactions Antonín Holý (1936–2012), Czech medicinal chemist known for acyclic nucleoside phosphonates, including Cidofovir, Adefovir and Tenofovir Mei Hong (born 1970), Chinese-American biophysical chemist known for development solid-state nuclear magnetic resonance to elucidate the structures and mechanisms of membrane proteins Frederick Gowland Hopkins (1861–1947), British biochemist, known for discovery of vitamins, Nobel Prize in Physiology or Medicine in 1929 Marjorie G.
== Death == On November 24, 2019, Cantelmo left a note at his house saying he was going for a walk and would return in a few hours. He hiked approximately four miles into the Angeles National Forest. His body was found on the West Fork Fascination Spring Trail. He had two folding knives with him. The Los Angeles County Department of Medical Examiner-Coroner ruled the death a suicide caused by sharp force injuries of the neck and forearms (case number 2019-08851). No suicide note was found at the scene. The medical examiner’s office noted that Cantelmo was under threat of losing his house and was scheduled to meet a realtor. Toxicology testing did not include DMT as a standard analyte. An expert who reviewed the autopsy information stated that the injuries were consistent with self-infliction and that there were no defense wounds.
Methemoglobinemia can be treated with supplemental oxygen and methylene blue. Methylene blue is given as a 1% solution (10 mg/ml) 1 to 2 mg/kg administered intravenously slowly over five minutes. Although the response is usually rapid, the dose may be repeated in one hour if the level of methemoglobin is still high one hour after the initial infusion. Methylene blue inhibits monoamine oxidase, and serotonin toxicity can occur if taken with an SSRI (selective serotonin reuptake inhibitor) medicine. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state. This is achieved by providing an artificial electron acceptor (such as methylene blue or flavin) for NADPH methemoglobin reductase (RBCs usually don't have one; the presence of methylene blue allows the enzyme to function at 5× normal levels). The NADPH is generated via the hexose monophosphate shunt. Genetically induced chronic low-level methemoglobinemia may be treated with oral methylene blue daily. Also, vitamin C can occasionally reduce cyanosis associated with chronic methemoglobinemia, and may be helpful in settings in which methylene blue is unavailable or contraindicated (e.g., in an individual with G6PD deficiency). Diaphorase (cytochrome b5 reductase) normally contributes only a small percentage of the red blood cell's reducing capacity, but can be pharmacologically activated by exogenous cofactors (such as methylene blue) to five times its normal level of activity.
Sources: en.wikipedia.org
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.
It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.
Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.